On March 17, 2025, Mark Oki, the Chief Financial Officer of Achieve Life Sciences Inc, purchased 10,000 shares of the company, according to a SEC Filing. Following this transaction, the insider now owns a total of 10,000 shares in the company. Achieve Life Sciences Inc (ACHV, Financial) is a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation. The company is focused on addressing the global smoking health epidemic through its innovative solutions. The insider transaction history for Achieve Life Sciences Inc indicates that there have been two insider buys in total over the past year, with no insider sells recorded during the same period. This recent purchase by Mark Oki is part of this trend.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
